Reinhard Lohmann - Concepedia

Author

Reinhard Lohmann

Gesellschaft zur Förderung angewandter Informatik

Also Known As

Hermann Soziale Institutionen, R C Lohmann, R LOHMANN, R. C. LOHMANN, R. C. Lohmann, R. Lohmann, R.C. Lohmann, REINHARD C. LOHMANN, Reinhard C. Lohmann, Reinhard Lohmann

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Gesellschaft zur Förderung angewandter Informatik London Health Sciences Centre Hôpital Notre-Dame Ottawa Regional Cancer Foundation Freie Universität Berlin

About

Reinhard Lohmann is an author at Gesellschaft zur Förderung angewandter Informatik specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	380
2	Engineering	1	1	11
3	Health Sciences	1	1	35
4	Natural Sciences	1	1	11
5	Biology	1	1	11

Reinhard Lohmann

Publications

973

Citations

H-Index

Page 1

	Year	Citations
Flavopiridol in Untreated or Relapsed Mantle-Cell Lymphoma: Results of a Phase II Study of the National Cancer Institute of Canada Clinical Trials Group C. Tom Kouroukis, Andrew Belch, Michael Crump, Journal of Clinical Oncology	2003	280
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group. James J. Rusthoven, Ian Quirt, N. Iscoe, Journal of Clinical Oncology	1996	167
Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma D. Scott Ernst, Elizabeth A. Eisenhauer, Nancy Wainman, Investigational New Drugs Surgical OncologyMedicineMelanomaPhase Ii StudyMetastatic Melanoma	2005	105
Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma Susan Burdette-Radoux, Richard Tozer, Reinhard Lohmann, Investigational New Drugs OncologyPhase Ii TrialMedicineMelanomaPharmacotherapy	2004	89
Follicular lymphoma: A survey of 75 cases with special reference to the syndrome resembling chronic lymphocytic leukaemia. Stephen Spiro, D. A. G. Galton, E. Wiltshaw, PubMed Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukaemiaBlast Cell LeukaemiaApparent Quiescence	1975	53
A neural network model for the prediction of membrane‐spanning amino acid sequences Reinhard Lohmann, Gisbert Schneider, Dirk Behrens, Protein Science	1994	46
Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group Ian Quirt, A. Bodurtha, Reinhard Lohmann, Investigational New Drugs Malignant DiseaseMedicineMelanomaPathologyPhase Ii Study	2002	44
External Quality Assessment in the Examination of Blood Films for Malarial Parasites Within Ontario, Canada Sam Thomson, Reinhard Lohmann, Linda Crawford, Archives of Pathology & Laboratory Medicine	2000	38
Flow cytometric reticulocyte analysis using thiazole orange; clinical experience and technical limitations Ian Chin‐Yee, Michael Keeney, Reinhard Lohmann Clinical & Laboratory Haematology Blood CellPathologyImmunophenotypingClinical ExperienceTechnical Limitations	2008	35
A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study Richard Tozer, Susan Burdette-Radoux, K. Berlanger, Investigational New Drugs MedicineCancer ManagementMelanomaAdvanced Malignant MelanomaDermatology	2002	20

Page 1